Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MBL1P (Mannose-binding lectin (protein A) 1, pseudogene 1) is a human pseudogene annotated with aliases such as COLEC3P and MBL1P1[5]. It is listed in gene databases but does not encode a functional protein; rather, it represents an inactive genomic sequence related to the collectin family. In rodents, genes homologous to human MBL are active (e.g., MBL-A and MBL-C), but in humans, complement activation via the lectin pathway is mediated by the functional MBL2 gene encoding Mannose-binding lectin (MBL)[1][3]. The protein product of MBL2 recognizes carbohydrate patterns on pathogens and apoptotic cells, initiates the complement system, and contributes to immune defense[3]. MBL1P does not have any recognized biological activity, disease association, or pharmacological relevance in human health or therapeutics[5]. MBL1P is a non-coding pseudogene with no functional protein, biological role, or relevance as a therapeutic target. For functional studies, drug targeting, or disease involvement in the context of mannose-binding lectins, the appropriate target is the protein encoded by MBL2 (Mannose-binding lectin 2)[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mannose-binding lectin (protein A) 1, pseudogene 1 (MBL1P).